The effect was seen across a wide variety of addictive and habit-forming substances, including cocaine, opioids, alcohol, ...

Research is quickly catching up. In the last few years, studies have linked GLP-1 drugs like Ozempic and Wegovy with fewer ...

A large new study suggests they may drastically reduce the risk substance use disorders and drug-related deaths.

Al-Aly and his colleagues found that people starting the GLP-1 drugs had lower risks of developing addiction to multiple ...

GLP-1 medications may quiet the brain signals behind addiction, reducing substance use disorders and overdose risk across ...

A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce ...

A growing body of research has looked at GLP-1 drugs for alcohol use disorder. A new study shows the medications could have a ...

My team and I set out to test whether GLP-1 drugs — medications like semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound), originally developed for diabetes and then approved for ...

Researchers at Washington University School of Medicine in St. Louis have shown in a new study that GLP-1 medications may be ...

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

Researchers at Washington University School of Medicine in St. Louis show in a new study that GLP-1 medications may be ...

GLP-1 drugs tied to lower addiction risk reduce substance use disorders and related harms in veterans with Type 2 diabetes, ...